Armata Pharmaceuticals, Inc. (ARMP) Reports Q1 Loss, Lags Revenue Estimates
Armata Pharmaceuticals (ARMP) delivered earnings and revenue surprises of 47.37% and 64.42%, respectively, for the quarter ended March 2025. Do…
2,065€
-1,20%
Echtzeit-Aktienkurs Armata Pharmaceuticals
Bid:
Ask:
Nachrichten zur Armata Pharmaceuticals Aktie
Amphastar Pharmaceuticals Inc. (AMPH) Q4 2024 Earnings Call Transcript
…
Armata Pharmaceuticals reports Q4 results
…